Cytori's StemSource(R) Cell Bank to Be Installed for Neo Derm in Hong Kong
May 04, 2011 07:00 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 4, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will install a comprehensive StemSource® Cell Bank in Hong Kong for Neo Derm (HK) Ltd. Building upon Neo Derm's current...
Cytori Appoints Tommy G. Thompson to its Board; Names Lloyd Dean Chairman
May 03, 2011 06:00 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 3, 2011) - On April 28, 2011, Cytori Therapeutics (NASDAQ: CYTX) elected the Honorable Tommy G. Thompson, former Secretary of the US Department of Health & Human...
Cytori to Webcast First Quarter Financial Results on May 5
April 27, 2011 08:00 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Apr 27, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will host a webcast to discuss its first quarter financial results and provide an update on its product development...
Cytori to Webcast at the Future Leaders in the Biotech Industry Conference on April 15, 2011
April 08, 2011 08:00 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Apr 8, 2011) - Cytori Therapeutics, Inc. (NASDAQ: CYTX) will present and provide a webcast of their corporate presentation at BioCentury's Future Leaders in the Biotech...
Cytori Grows Product Revenues 41% Year-Over-Year, Advances Cardiac Device Product Pipeline
March 10, 2011 16:05 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - March 10, 2011) - Cytori Therapeutics (NASDAQ: CYTX) grew
product sales 41% and made substantial progress in advancing its
cardiovascular device product pipeline during...
Cytori Patents Method of Making Stem and Regenerative Cell-Enriched Fat Grafts
March 08, 2011 08:30 ET
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - March 8, 2011) - Cytori (NASDAQ: CYTX) received US Patent No. 7,901,672 ('the 672 patent) today from the United States Patent and Trademark Office for a method of...
Europäische Studie belegt langfristigen Erfolg von neuem Verfahren zur Brustrekonstruktion - die Ergebnisse der Studie RESTORE-2 für das Celution(R) System von Cytori liegen vor
March 03, 2011 16:30 ET
|
Cytori Therapeutics, Inc.
ZUG, SWITZERLAND und SAN DIEGO, CA--(Marketwire - March 3, 2011) -
Die Ergebnisse einer europäischen Studie über die Brustrekonstruktion mithilfe eines neuen minimal-invasiven Verfahrens...
Une nouvelle méthode de reconstruction des seins s’avère une réussite à long terme lors d’un essai européen ; informations émanant de l’étude RESTORE-2 du système Celution(R) de Cytori
March 03, 2011 14:34 ET
|
Cytori Therapeutics, Inc.
ZUG, SUISSE et SAN DIEGO, CA--(Marketwire - March 3, 2011) -
Les résultats de l’essai européen de reconstitution des seins, faisant appel à une nouvelle méthode très...
La nuova procedura di ricostruzione del seno si dimostra essere un successo a lungo termine secondo una sperimentazione europea; dati riportati dallo Studio RESTORE-2 del sistema Celution(R) di Cytori
March 03, 2011 11:59 ET
|
Cytori Therapeutics, Inc.
ZUG, SWITZERLAND e SAN DIEGO, CA--(Marketwire - March 3, 2011) -
I risultati di una sperimentazione europea sulla ricostruzione del seno con una nuova procedura minimamente invasiva per riparare dei...
Nuevo procedimiento de reconstrucción mamaria muestra éxito a largo plazo en ensayo clínico europeo según datos del estudio RESTORE-2 del sistema Celution(R) de Cytori
March 02, 2011 21:20 ET
|
Cytori Therapeutics, Inc.
ZUG, SUIZA, y SAN DIEGO, CA--(Marketwire - March 2, 2011) -
Los resultados de un ensayo clínico de reconstrucción mamaria en Europa mediante un nuevo procedimiento mínimamente...